Studies have shown that butyrate combined with GLP-1 can promote differentiation of pancreatic progenitor cells into insulin-producing cells, inducing the proliferation of insulin-producing cells, promoting the synthesis and release of insulin (78), improving blood glucose tolerance, insulin resistance, dyslipidiasis, and inflammation, and reducing body fat in diabetic patients (79). The gene discussed is INS; the disease is Insulin resistance.